Used as an intermediate in the synthesis of antiviral and pharmaceutical compounds, particularly in the development of nucleoside analogs. Its protected ribofuranoside structure makes it valuable for selective glycosylation reactions in medicinal chemistry. The dichlorobenzyl groups act as protecting groups that can be selectively removed, allowing stepwise construction of complex sugar-containing molecules. Commonly employed in research settings for designing drug candidates targeting RNA viruses.